Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): June 22, 2009
PATIENT
SAFETY TECHNOLOGIES, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
001-09727
|
13-3419202
|
(State
or other jurisdiction
|
(Commission
File Number)
|
(IRS
Employer
|
of
incorporation)
|
|
Identification
No.)
|
43460
Ridge Park Drive, Suite 140
Temecula,
California 92590
(Address
of principal executive offices and zip code)
Registrant’s
telephone number, including area code: (951) 587-6201
N/A
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under and of the following
provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
Soliciting
material pursuant to Rule 14A-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4 (c))
|
Item
5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
(d) On
June 22, 2009, the Board of Directors of Patient Safety Technologies, Inc. (the
“Company”) appointed Loren L. McFarland and Howard E. Chase as directors to fill
the vacancies created with the departure of David M. Augustine and David I.
Bruce. Messrs. McFarland and Chase will serve until their successors
are duly elected or appointed and qualified.
Mr.
McFarland has been appointed to the audit committee and the compensation
committee. Mr. McFarland will serve as the Chair of the audit
committee. Mr. Chase has been appointed to the audit committee, the
nominating committee and the compensation committee. Mr. Chase will
serve as the Chair of the nominating committee and the compensation
committee.
Mr.
McFarland and Mr. Chase were each granted a non-statutory option to
purchase up to 200,000 shares of the Company’s common stock, at an exercise
price equal to the fair market value of the common stock on the date of
grant. The options are immediately exercisable as to all shares and
have a term of ten years from the date of grant.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
PATIENT
SAFETY TECHNOLOGIES, INC.
|
|
|
|
|
|
|
Date: June
26, 2009
|
By:
|
/s/ Mary Lay
|
|
|
Name: Mary
Lay
|
|
|
Title: Interim
Chief Financial Officer
|
|
|
|